Product NDC: | 0955-1020 |
Proprietary Name: | Docetaxel |
Non Proprietary Name: | Docetaxel |
Active Ingredient(s): | 20 mg/mL & nbsp; Docetaxel |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0955-1020 |
Labeler Name: | Winthrop U.S. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020449 |
Marketing Category: | NDA |
Start Marketing Date: | 20101021 |
Package NDC: | 0955-1020-01 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (0955-1020-01) > 1 mL in 1 VIAL, GLASS |
NDC Code | 0955-1020-01 |
Proprietary Name | Docetaxel |
Package Description | 1 VIAL, GLASS in 1 CARTON (0955-1020-01) > 1 mL in 1 VIAL, GLASS |
Product NDC | 0955-1020 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Docetaxel |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101021 |
Marketing Category Name | NDA |
Labeler Name | Winthrop U.S. |
Substance Name | DOCETAXEL |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |